Tin tức & Cập nhật

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021

In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021